0001824293-23-000104.txt : 20230424
0001824293-23-000104.hdr.sgml : 20230424
20230424183014
ACCESSION NUMBER: 0001824293-23-000104
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230421
FILED AS OF DATE: 20230424
DATE AS OF CHANGE: 20230424
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hertz Walter Marc
CENTRAL INDEX KEY: 0001971132
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40034
FILM NUMBER: 23841238
MAIL ADDRESS:
STREET 1: 2223 AVIENDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GRI BIO, Inc.
CENTRAL INDEX KEY: 0001824293
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824369909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (619) 400-1171
MAIL ADDRESS:
STREET 1: 2223 AVENIDA DE LA PLAYA
STREET 2: SUITE 208
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Vallon Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20200910
4
1
wf-form4_168237539956604.xml
FORM 4
X0407
4
2023-04-21
0
0001824293
GRI BIO, Inc.
GRI
0001971132
Hertz Walter Marc
C/O GRI BIO, INC.
2223 AVENIDA DE LA PLAYA, SUITE 208
LA JOLLA
CA
92037
1
1
1
0
Chief Executive Officer
0
Common Stock
2023-04-21
4
A
0
385510
A
385510
D
Received in exchange for 10,307,793 shares of common stock of GRI Bio, Inc. ("GRI"), pursuant to the Agreement and Plan of Merger, dated December 13, 2022, by and among Vallon Pharmaceuticals, Inc. (the "Company"), Vallon Merger Sub, Inc. and GRI Bio, Inc. (the "Merger"). Per the terms of the Merger, each share of GRI common stock was converted into the right to receive 0.0374 shares of the Company's common stock. In connection with the Merger, the Company effected a reverse stock split of the Company's common stock at a ratio of 1-for-30 (the "Reverse Split"). Unless noted otherwise, all references to share amounts in this Form 4 reflect the Reverse Split.
/s/ Leanne Kelly, Attorney-in-Fact
2023-04-24